They are designed to act like one of these hormones, known as glucagon-like peptide 1 (GLP-1). The use of Mounjaro, also known as tirzepatide, was recorded as a contributing factor on Susan’s death certificate which lists multiple organ failure ...

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the NHS. Susan McGowan, 58, took two low-dose injections of tirzepatide, known under the brand name Mounjaro, over the course of about two weeks before her death on 4 September.

Susan McGowan took two doses of tirzepatide, sold under the brand name Mounjaro, before she died on 4 September

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates appetite and digestion. The medications control blood sugar and help people eat less,

A weight drug recently legalised in the UK contributed to the death of a 58-year-old nurse, according to a new report.